Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits

The control of disease outbreaks requires rapid and accurate diagnostic tests. So far, testing for COVID-19 has relied on methods suited only for well-equipped centralised laboratories. The scope of the EU-funded CORONADX project is to develop tests that can be performed by minimally or briefly trained personnel at primary healthcare units, mobile laboratories or even at home. These include point-of-care tests for first-line diagnosis and second-line diagnostics that require portable equipment. Their development will be supported by clinical and molecular epidemiological studies. The project's deliverables will facilitate the fast detection and surveillance of the COVID-19 pandemic, contributing to the clinical management of infected patients.